Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday(Institute of Cancer Research), Nazneen Rahman(Institute of Cancer Research), Elise Ruark(Institute of Cancer Research), Zosia Miedzybrodzka(NHS Grampian), Margaret Warren-Perry(Institute of Cancer Research), Julian Adlard(Chapel Allerton Hospital), Clare Turnbull(Institute of Cancer Research), Lynn Greenhalgh, Jessica Frankum(Institute of Cancer Research), Antonis C. Antoniou(Weatherford College), Glen Brice(St George's, University of London), Patrick J. Morrison(Belfast Health and Social Care Trust), Deborah Hughes(Institute of Cancer Research), Julian Barwell(London North West Healthcare NHS Trust), Ajith Kumar(Great Ormond Street Hospital), Susan Shanley(Royal Marsden NHS Foundation Trust), Bolot Kalmyrzaev(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Katie Snape(Institute of Cancer Research), D. Gareth Evans(Manchester Academic Health Science Centre), Christopher J. Lord(Institute of Cancer Research), Jonathan Berg(University of Dundee), Mark T. Rogers, Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Lisa Walker(Oxford University Hospitals NHS Trust), Anthony Renwick(Institute of Cancer Research), Mary Porteous(University of Edinburgh), Alan Ashworth(University of California, San Francisco), Fiona Douglas(University of Southern California), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Sheila Seal(Institute of Cancer Research), Rosemarie Davidson(The Netherlands Cancer Institute), Carole Brewer(Royal Devon and Exeter Hospital), Emma Ramsay(Institute of Cancer Research), Alex Henderson(Centre for Life), Joan Paterson, Cyril Chapman(Birmingham Women's Hospital), Angela F. Brady(Northwick Park Hospital), Fiona Lalloo(Manchester University NHS Foundation Trust), Jackie Cook(Sheffield Children's Hospital), Diana Eccles(Princess Anne Hospital), Georgina R. Bowden(Institute of Cancer Research)
Cited by 545
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k